Hello team,
Sharing a quick update regarding EAU26. Mdxhealth is pleased to announce a GPS abstract utilizing the ProMPT data cohort, in conjunction with researchers from Unviersity of Cambridge and University of Oxford. The late breaking abstract is scheduled for presentation later this week. Because the abstract content is embargoed, only limited information is publicly available at this time.
Genomic Prostate Score predicts adverse oncological outcomes in patients with prostate cancer undergoing active surveillance, surgery, or radiotherapy in the ProMPT study
Presentation: Friday, March 13, 13:00 – 15:00
Location: Orange Area Room 3
The abstract is available to review on the EAU webpage, accessible with a login:
https://urosource.uroweb.org/resource-centres/EAU26/269110/abstract
Please note at this time:
- We can reference only what is visible on the public webpage.
- We cannot discuss results, data, or interpret the abstract prior to presentation.
- External communications should promote the session only, not the content.
Marketing has prepared compliant external email to make customers aware of the session, should you receive related inquiries.
If you have questions about how the session can be shared or discussed compliantly, feel free to reach out and we can help guide the communication approach. We will also follow up post-presentation when the abstract is no longer embargoed to share key takeaways and the poster.